TSS
TENX icon

Two Sigma Securities’s Tenax Therapeutics TENX Stock Holding History

Two Sigma Securities’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,213
Closed -$29K – 3581
2023
Q3 		$29K Buy
1,213
+966
+391% +$24.5K ﹤0.01% 2530
2023
Q2 		$5.93K Sell
247
-290
-54% -$7.74K ﹤0.01% 2655
2023
Q1 		$20K Buy
537
+495
+1,179% +$51.6K ﹤0.01% 2364
2022
Q4 		$7.54K Buy
42
+28
+200% +$6.16K ﹤0.01% 2401
2022
Q3 		$4K Buy
14
+2
+17% +$803 ﹤0.01% 2488
2022
Q2 		$6K Buy
+12
New +$12K ﹤0.01% 2100
2021
Q1 		– Sell
-8
Closed -$24K – 1700
2020
Q4 		$24K Buy
+8
New +$14.7K ﹤0.01% 1596
2018
Q1 		– Sell
-1
Closed -$11K – 2949
2017
Q4 		$11K Hold
1
– – ﹤0.01% 1671
2017
Q3 		$8K Buy
+1
New +$14.9K ﹤0.01% 875

Other funds holding TENX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Securities's TENX Position: Q4 2023 in Review

Two Sigma Securities sold out of Tenax Therapeutics (TENX) in Q4 2023, closing a stake of 1,213 shares — an estimated $29K sold.

Two Sigma Securities first reported a position in TENX in Q3 2017 and held it in 9 quarters. The position peaked at $29K in Q3 2023. 16 funds tracked by Wall St. Rank hold TENX as of Q4 2023.

  • Two Sigma Securities reported no remaining Tenax Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Securities sold 1,213 Tenax Therapeutics shares in Q4 2023, an estimated $29K.
  • Two Sigma Securities first reported a position in Tenax Therapeutics in Q3 2017 and held it in 9 quarters.
  • Two Sigma Securities's Tenax Therapeutics position peaked at $29K in Q3 2023.
  • 16 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q4 2023.

Based on Two Sigma Securities's 13F filing for Q4 2023, filed 14 Feb 2024.